Hjem › Dermatomyositis › Texas › Houston
Dermatomyositis kliniske forsøg i Houston, TX
5 studier for Dermatomyositis søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- UT MD Anderson Cancer Center, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekruttererFase 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RekruttererFase 3
- Nerve & Muscle Center of Texas, Houston
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RekruttererFase 3
- Nerve & Muscle Center of Texas, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RekruttererFase 1
- Nerve and Muscle Center of Texas, Houston
Dermatomyositis forsøg i andre byer
- Durham, NC8 studier
- Washington, DC7 studier
- New York City, NY5 studier
- Pittsburgh, PA5 studier
- Boston, MA5 studier
- Philadelphia, PA4 studier
- Baltimore, MD4 studier
- Miami, FL4 studier
- Cleveland, OH3 studier
- Kansas City, KS3 studier
- Jacksonville, FL3 studier
- Aurora, CO3 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.